Dasabuvir/ombitasvir/paritaprevir/ritonavir/sorafenibVarious toxicities: 3 case reports

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-018-55013-9
中图分类号
学科分类号
摘要
引用
收藏
页码:113 / 113
相关论文
共 50 条
  • [22] Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports
    Ponziani, Francesca Romana
    Siciliano, Massimo
    Lionetti, Raffaella
    Pasquazzi, Caterina
    Gianserra, Laura
    D'Offizi, Gianpiero
    Gasbarrini, Antonio
    Pompili, Maurizio
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 70 (02) : 297 - 300
  • [24] Ombitasvir/Paritaprevir/Ritonavir
    Mistanoglu Ozatag, Duru
    Korkmaz, Pinar
    Cosgun, Suleyman
    Konya, Petek
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (04): : 736 - 741
  • [26] Ombitasvir/paritaprevir/ritonavir
    Hunyady, Bela
    Abonyi, Margit
    Gerlei, Zsuzsanna
    Gervain, Judit
    Horvath, Gabor
    Jancsik, Viktor
    Lengyel, Gabriella
    Makkai, Erzsebet
    Par, Alajos
    Peter, Zoltan
    Pusztay, Margit
    Ribiczey, Pal
    Rokusz, Laszlo
    Sarrazin, Christoph
    Schneider, Ferenc
    Susser, Simone
    Szalay, Ferenc
    Tornai, Istvan
    Tusnadi, Anna
    Ujhelyi, Eszter
    Werling, Klara
    Makara, Mihaly
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2018, 4 (02) : 83 - 90
  • [28] Ombitasvir/paritaprevir/ritonavir + dasabuvir +/-ribavirin in real world hepatitis C patients
    Nicole Loo
    Eric Lawitz
    Naim Alkhouri
    Jennifer Wells
    Carmen Landaverde
    Angie Coste
    Rossalynn Salcido
    Michael Scott
    Fred Poordad
    World Journal of Gastroenterology, 2019, (18) : 2229 - 2239
  • [29] WORKING TOGETHER TO TACKLE HCV INFECTION: OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR COMBINATION
    Gamal, N.
    Andreone, P.
    DRUGS OF TODAY, 2015, 51 (05) : 303 - 314